Quantcast

Latest Ibritumomab tiuxetan Stories

2013-08-26 23:24:00

In a Breaking News Exclusive, Jamie Reno writes how GSK's spokesperson informed him that Bexxar, a lifesaving cancer drug is being discontinued in February 2014. A 17-year cancer survivor who's been in remission for 13 years because of radio-immunotherapy, Reno discusses the ramifications and reasons behind the cancellation of Bexxar. San Diego, CA (PRWEB) August 26, 2013 According to Jamie Reno, an award-winning correspondent for Newsweek, he received a note from GlaxoSmithKline...

2013-07-10 15:56:06

New study evaluates maximum tolerated dose and clinical response A new treatment option for patients with relapsing follicular, mantle cell and other indolent B-cell lymphomas has been determined safe and feasible by researchers exploring the potential of a low energy beta-emitter radiopharmaceutical. According to data published in the July issue of The Journal of Nuclear Medicine, the use of 177Lu-DOTA-rituximab as a radioimmunotherapy results in a high rate of tumor response while using...

2013-06-11 15:04:44

Research compares standard treatment and addition of targeted therapy with radiolabeled antibodies that track and kill lymphoma cancer cells A new patient protocol for aggressive and recurrent lymphoma that combines intensive chemotherapy and radioimmunotherapy (RIT) may become the most powerful cancer-killing therapy available, with the hope that patients´ lymphoma can be eradicated as they prepare for bone marrow transplant, say researchers at the 2013 Annual Meeting of the Society...

2013-06-11 14:47:44

Comprehensive dosimetry based on 3D medical images estimate best possible dose for targeted radioimmunotherapy (RIT) in patients with invasive blood cancer Outcomes can be bleak for non-Hodgkin lymphoma (NHL), a cancer that develops in the white blood cells of the immune system. Accurate estimation of radiation absorbed dose in radioimmunotherapy (RIT) based on state-of-the-art 3D imaging could lead to more personalized and effective treatments to improve patients´ chances of living...

2012-08-22 12:19:10

A University of Rochester Medical Center study challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient is carefully examined and staged at diagnosis. The research underlines the fact that when cancer strikes, modern patients and their oncologists across the United States are taking many diverse treatment paths when there is scant data to support one method over another. This study...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related